Prof. Dr. DİDEM TAŞTEKİN

Metrikler

Yayın

105

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

542

H-İndeks (WoS)

Atıf (Scopus)

640

H-İndeks (Scopus)

Atıf (Scholar)

440

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Eğitim Bilgileri

2011 - 2013

Tıpta Yandal Uzmanlık

Necmettin Erbakan Üniversitesi, Tıp Fakültesi, Türkiye

2001 - 2005

Tıpta Uzmanlık

Atatürk Üniversitesi, Tıp Fakültesi, Türkiye

1985 - 1992

Lisans

Necmettin Erbakan Üniversitesi, Tıp Fakültesi, Türkiye

Yaptığı Tezler

2013

Tıpta Yandal Uzmanlık

Oksaliplatin alan kanser hastalarında akcığer fibrozisi

Necmettin Erbakan Üniversitesi, Tıp Fakültesi

2005

Tıpta Uzmanlık

Akciğer kanserlerinde plazma homosistein, vitamin B12 ve folik asit düzeyleri

Atatürk Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri

Araştırma Alanları

Avesis Araştırma Alanları: Tıp, Sağlık Bilimleri, Dahili Tıp Bilimleri, İç Hastalıkları, Onkoloji, Cerrahi Tıp Bilimleri, Genel Cerrahi, Cerrahi Onkoloji

WoS Araştırma Alanları: Klinik Tıp (Med), Klinik Tıp, Onkoloji

Scopus Araştırma Alanları: Onkoloji

Akademik Faaliyetlere Dayalı Araştırma Alanları

Avesis Araştırma Alanları

WoS Araştırma Alanları

Scopus Araştırma Alanları

Akademik Ünvanlar / Görevler

2023 - Devam Ediyor

Prof. Dr.

İstanbul Üniversitesi, Onkoloji Enstitüsü, Klinik Onkoloji Ana Bilim Dalı

Yönetimsel Görevler

2006 - 2007

Dekan Yardımcısı

Kafkas Üniversitesi, Tıp Fakültesi

Makaleler

2026

1. Role of gallium-68-labeled FAPI-PET imaging in oncology: Results of a study in 310 patients.

Harbi E., BOZBEY H. U., Bilgin R., TAŞTEKİN D.

Journal of Clinical Oncology , cilt.44, 2026 (SCI-Expanded, Scopus)

2026

2. Oncological Outcomes of Breast-Conserving Surgery Versus Mastectomy in Invasive Lobular Breast Cancer: A Single-Center Retrospective Study

ÇOKGEZER S., Safaraliyeva A., Topuz S., Şenkal M., AK N., TAŞTEKİN D., et al.

Medicina (Lithuania) , cilt.62, sa.4, 2026 (SCI-Expanded, Scopus)

2026

3. Post-Chemotherapy Changes and Agreement of CT-Derived Body Composition at L3 and T12 in Older Patients with Metastatic Colorectal Cancer: Associations with Nutritional Indices and Outcomes

Yıldız A., AHMED M. A., Eren N. N., AZİZY A., ARTAN S., ÇOKGEZER S., et al.

Nutrients , cilt.18, sa.7, 2026 (SCI-Expanded, Scopus)

2026

4. Prognostic Role of Endocan and Platelet-Derived Growth Factor Isoforms in Metastatic Colorectal Cancer

Yildiz A., Ahmed M. A., Azizy A., Çokgezer S., Ulufer B., Soydinc H., et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.27, sa.6, 2026 (SCI-Expanded, Scopus)

2026

5. Enhancing the efficacy of VEGF inhibitors by co-inhibition of HIF in the treatment of glioblastoma

Harbi E., Byrne Y. Y., BOZBEY H. U., TAŞTEKİN D., Oncul O., Hosseiny S., et al.

Apoptosis , cilt.31, sa.2, 2026 (SCI-Expanded, Scopus)

2026

6. Evaluating Comorbidity Scores in Geriatric Ovarian Cancer: A Retrospective Cohort Analysis

ÇOKGEZER S., AK N., Senkal M., Safaraliyeva A., TAŞTEKİN D., SAİP P. M.

Medicina (Lithuania) , cilt.62, sa.1, 2026 (SCI-Expanded, Scopus)

2025

7. IGF Pathway Components as Potential Biomarkers in Gastric Cancer

CEYLANER B., ŞAHİN F., YILDIZ A., TAŞTEKİN D., GÖK A. F. K., BAYKAL A. T.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.26, sa.22, 2025 (SCI-Expanded, Scopus)

2025

8. A Pilot Study of Exploring miRNA-Protein Interaction Networks in Pancreatic Ductal Adenocarcinoma Patients: Implications for Diagnosis and Prognosis

Şen S., Özgel M. Ç., Tunçer Ş. B., Bozbey H. U., Karabulut S., Taştekin D.

DIAGNOSTICS , cilt.15, sa.19, 2025 (SCI-Expanded, Scopus)

2025

9. Enhancing Antitumor Efficacy of MUC1 mRNA Nano-Vaccine by CTLA-4 siRNA-Mediated Immune Checkpoint Modulation in Triple Negative Breast Cancer Mice Model

Monfaredan A., Şen S., Fathi N. K., Taştekin D., Hosseininasab A., Bozbey H. U., et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES , cilt.26, sa.17, 2025 (SCI-Expanded, Scopus)

2025

10. Exosome Enveloped by Nano Lipid Particle a New Model for Signal Transducer and Activator of Transcription 3 Silencer Ribonucleic Acid Delivery System to a Glioblastoma Mice Model

Monfaredan A., ŞEN S., Hosseininasab A., TAŞTEKİN D., Fazli G., Bozbey H. U., et al.

CANCERS , cilt.17, sa.10, 2025 (SCI-Expanded, Scopus)

2024

11. Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients: A retrospective study

DEMİRCİ N. S., AZİZY A., Paksoy N., Doǧan I., KARABULUT S., Karahan L., et al.

Medicine (United States) , cilt.103, sa.9, 2024 (SCI-Expanded, Scopus)

2024

12. Investigation of the potential of miRNA candidates as non-invasive biomarkers for the diagnosis and follow-up of colorectal cancer

KARABULUT S., ŞEN S., OĞUZ SOYDİNÇ H., Dogan I., TAŞTEKİN D., Karabulut M., et al.

PATHOLOGY RESEARCH AND PRACTICE , cilt.254, 2024 (SCI-Expanded, Scopus)

2024

13. Disease characteristics and prognostic factors of colorectal cancer patients with bone metastasis: A real-world data from Turkey.

Karabulut S., Afsar C. U., Khanmammadov N., Karahan L., Paksoy N., Dogan I., et al.

Journal of cancer research and therapeutics , 2024 (SCI-Expanded, Scopus)

2024

14. Is there any diagnostic value of serum caveolin-1 levels on the determination of pancreatic adenocarcinoma?

Karabulut S., Afsar C. U., Paksoy N., Ferhatoglu F., Dogan I., Tastekin D.

Journal of cancer research and therapeutics , 2024 (SCI-Expanded, Scopus)

2024

15. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

KÖSTEK O., Demirel A., Hacıoğlu M. B., TAŞTEKİN D., KARABULUT S., Gündogdu A., et al.

Journal of Chemotherapy , cilt.36, sa.7, ss.613-621, 2024 (SCI-Expanded, Scopus)

2023

16. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

Ünal Ç., AZİZY A., KARABULUT S., TAŞTEKİN D., AKYILDIZ A., YAŞAR S., et al.

The oncologist , cilt.28, sa.10, ss.875-884, 2023 (SCI-Expanded, Scopus)

2023

17. Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience

TAŞTEKİN D., Paksoy N., DOĞAN İ., Ferhatoglu F., KHANMAMMADOV N., Bozbey H. U., et al.

Journal of cancer research and therapeutics , cilt.19, sa.2, ss.253-258, 2023 (SCI-Expanded, Scopus)

2023

18. Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+rectal cancer: Istanbul R-02 phase II randomized study

Senyurek S., Saglam S., Saglam E. K., Yanar H. T., Gok K., TAŞTEKİN D., et al.

ONCOLOGY RESEARCH , cilt.31, sa.5, ss.689-696, 2023 (SCI-Expanded, Scopus)

2022

19. Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group

Erol C., Nahit Sendur M. A., Bilgetekin I., Garbioglu D. B., Hamdard J., Akbas S., et al.

Journal of cancer research and therapeutics , cilt.18, 2022 (SCI-Expanded, Scopus)

2022

20. Quantification of cell-free circulating mitochondrial DNA copy number variation in hepatocellular carcinoma

Yalcinkaya B., Tastekin D., Guezelbulut F., Akgoz M., PENÇE S.

REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , cilt.68, sa.9, ss.1161-1165, 2022 (SCI-Expanded, Scopus)

2022

21. Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study

Paksoy N., Ferhatoglu F., DOĞAN İ., Khanmammadov N., Bozbey H. U., KARABULUT S., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.37, sa.4, ss.478-483, 2022 (ESCI, Scopus, TRDizin)

2022

22. Recent Advances in Immunotherapy in the Treatment of Gastrointestinal Tract Cancers

Karabulut S., Topalgokceli M. S., Tastekin D.

EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY , cilt.6, sa.1, ss.12-15, 2022 (ESCI, TRDizin)

2021

23. Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study

Karabulut S., Dogan I., Usul Afsar C., Karabulut M., Karaman S., Ferhatoglu F., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.6, ss.1357-1363, 2021 (SCI-Expanded, Scopus)

2021

24. WHAT'S NEW IN METASTATIC COLON CANCER TREATMENT?

Karabulut S., Karabulut M., Tastekin D.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.84, sa.3, ss.425-429, 2021 (ESCI, TRDizin)

2021

25. Role of mir-33a, mir-203b, mir361-3p, and mir-424 in hepatocellular carcinoma

Yalcinkaya B., Guzel Tanoglu E., Tastekin D., Pence S.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.2, ss.638-643, 2021 (SCI-Expanded, Scopus, TRDizin)

2021

26. Temozolomide and capecitabine (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.

Dogan I., Tastekin D., Karabulut S., Sakar B.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.3, 2021 (SCI-Expanded, Scopus)

2020

27. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey

Hacioglu M. B., Kostek O., Karabulut S., Tastekin D., SEZGİN GÖKSU S., Alandag C., et al.

JOURNAL OF BUON , cilt.25, sa.4, ss.1897-1903, 2020 (SCI-Expanded, Scopus)

2020

28. Examination of the expression levels of MACC1, Filamin A and FBXW7 genes in colorectal cancer patients

Yesilkaya F., Tastekin D., Al Saadoni H., Ergen A., Pence S.

NORTHERN CLINICS OF ISTANBUL , cilt.7, sa.1, ss.1-5, 2020 (ESCI, TRDizin)

2019

29. Investigation of JAM-A (rs790056) and LFA-1 (rs8058823) gene variants in Turkish colorectal cancer patients

Caykara B., Alsaadoni H., Pence H. H., Pence S., Aydogan H., Tastekin D.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.10, ss.872-876, 2019 (SCI-Expanded, Scopus, TRDizin)

2019

30. The Association of Pancreatic Cancer and PALB2 Gene Mutations in the Turkish Population

Turkcan G. K., Odemis D., Avsar M., Tuncer S. B., Erciyas S., Erdogan Ö., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.34, sa.4, ss.283-290, 2019 (ESCI, Scopus, TRDizin)

2019

31. ROLE OF INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 (IGFBP-3) IN THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA AND MONITORING TREATMENT RESPONSE

Bademler S., Ucuncu W. Z., Sari M., Yasasever C., Afsar C. U., Tastekin D.

ACTA MEDICA MEDITERRANEA , cilt.35, sa.1, ss.71-75, 2019 (SCI-Expanded, Scopus)

2018

32. Evaluation of JAM-A (rs790056) and LFA-1 (rs8058823) Variants in Colorectal Cancer

Caykara B., Alsaadoni H., PENÇE H. H., Pence S., Aydogan H., Tastekin D.

ACTA PHYSIOLOGICA , cilt.225, ss.25, 2018 (SCI-Expanded, Scopus)

2018

33. Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers.

Gurdal N., Fayda M., ALISHEV N., Bakir B., Tastekin D., Aykan F., et al.

Tumori , cilt.104, ss.266-272, 2018 (SCI-Expanded, Scopus)

2018

34. Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)

Inal A., Kodaz H., Odabas H., Duran A. O., ŞEKER M. M., Inanc M., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.14, sa.3, ss.578-582, 2018 (SCI-Expanded, Scopus)

2017

35. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection

Aydin D., Sendur M. A., KEFELİ U., Unal O. U., Tastekin D., Akyol M., et al.

CLINICAL COLORECTAL CANCER , cilt.16, sa.3, ss.220-227, 2017 (SCI-Expanded, Scopus)

2016

36. Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO)

Aydin D., Sendur M. A., KEFELİ U., Unal O. U., TAŞTEKİN D., Akyol M., et al.

JOURNAL OF BUON , cilt.21, sa.5, ss.1242-1249, 2016 (SCI-Expanded, Scopus)

2016

37. Importance of Performing Radiotherapy and Chemotherapy in the Same Clinic and Bad Prognostic Factors for Small-cell Lung Cancer Patients

Kiziltan H. S., TAŞTEKİN D., ERİŞ A. H., Taspinar O., Ismaylova M., MAYADAĞLI A.

BEZMIALEM SCIENCE , cilt.4, sa.2, ss.51-55, 2016 (ESCI, TRDizin)

2016

38. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.

Tas F., Bilgin E., Tastekın D., Erturk K., Duranyıldız D.

Journal of gastrointestinal cancer , cilt.47, ss.182-6, 2016 (Scopus)

2016

39. Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.

BIOMEDICAL REPORTS , cilt.4, sa.5, ss.609-614, 2016 (ESCI, Scopus)

2016

40. Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome

Tas F., Bılgın E., Karabulut S., Tastekın D., Duranyıldız D.

MOLECULAR AND CLINICAL ONCOLOGY , cilt.4, sa.4, ss.655-659, 2016 (ESCI, Scopus)

2016

41. Clinical significance of serum laminin levels in patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.

BIOMEDICAL REPORTS , cilt.4, sa.4, ss.485-488, 2016 (ESCI, Scopus)

2016

42. Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients

Tas F., Karabulut S., Tastekin D., Duranyildiz D.

BIOMEDICAL REPORTS , cilt.4, sa.4, ss.489-492, 2016 (ESCI, Scopus)

2016

43. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers?

Erturk K., Tastekin D., Bilgin E., Serilmez M., Bozbey H. U., Sakar B.

BIOMEDICINE & PHARMACOTHERAPY , cilt.77, ss.86-91, 2016 (SCI-Expanded, Scopus)

2016

44. Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?

Erturk K., Tastekin D., Gundogdu G., Tas F., Vatansever S.

BIOMEDICINE & PHARMACOTHERAPY , cilt.77, ss.27-29, 2016 (SCI-Expanded, Scopus)

2016

45. Clinical significance of serum protease activated receptor1 levels in patients with lung cancer

Erturk K., Tastekin D., Bilgin E., Tas F., Disci R., Duranyildiz D.

European Review for Medical and Pharmacological Sciences , cilt.20, sa.2, ss.243-249, 2016 (SCI-Expanded, Scopus)

2016

46. The relationship of beck depression inventory with vitamin D levels and visceral fat mass in cancer patients

Tuna S., Mert M., Soyluk O., Okuturlar Y., Kocoglu H., Tastekin D.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.5, ss.8719-8724, 2016 (SCI-Expanded, Scopus)

2016

47. Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer

Erturk K., Tastekin D., Serilmez M., Bilgin E., Bozbey H. U., Vatansever S.

TUMOR BIOLOGY , cilt.37, sa.1, ss.405-412, 2016 (SCI-Expanded, Scopus)

2015

48. Plasma homocysteine, folate and vitamin B12 levels in patients with lung cancer.

Tastekın D., Erturk K., Bozbey H. U., Olmuscelık O., Kızıltan H., Tuna S., et al.

Experimental oncology , cilt.37, ss.218-22, 2015 (SCI-Expanded, Scopus)

2015

49. Bilateral Cystoid Macular Edema Secondary to Paclitaxel Treatment

Tezcan Y., Surmeli M., Tastekin D., Koc M.

ARCHIVES OF IRANIAN MEDICINE , cilt.18, sa.9, ss.606-607, 2015 (SCI-Expanded, Scopus)

2015

50. Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma

Turan N., Benekli M., Unal O. U., Unek I. T., Tastekin D., Dane F., et al.

CHINESE JOURNAL OF CANCER RESEARCH , cilt.27, sa.4, ss.408-416, 2015 (SCI-Expanded, Scopus)

2015

51. Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer

Arslan D., Tural D., Koca T., Tastekin D., Cerkesli A. K., Basaran H., et al.

JOURNAL OF BUON , cilt.20, sa.2, ss.573-579, 2015 (SCI-Expanded, Scopus)

2015

52. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , cilt.36, sa.3, ss.2097-103, 2015 (SCI-Expanded, Scopus)

2015

53. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

BIOMEDICINE & PHARMACOTHERAPY , cilt.70, ss.19-23, 2015 (SCI-Expanded, Scopus)

2015

54. The Effects of Topical Insulin Application on Wound Healing

Kargin S., Tastekin D., Kilic K., Cezik A., Cakir M., Kucukkartallar T., et al.

EUROPEAN JOURNAL OF GENERAL MEDICINE , cilt.12, sa.4, ss.302-306, 2015 (ESCI, Scopus, TRDizin)

2015

55. Progesterone receptor status in determining the prognosis of estrogen receptor positive/HER2 negative breast carcinoma patients

Bal O., Arslan U. Y., Durnali A., Uyetrk U., Demirci A., Tastekin D., et al.

JOURNAL OF BUON , cilt.20, sa.1, ss.28-34, 2015 (SCI-Expanded, Scopus)

2015

56. Circulating annexin A2 as a biomarker in gastric cancer patients: Correlation with clinical variables

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

Biomedicine and Pharmacotherapy , cilt.69, ss.237-241, 2015 (SCI-Expanded, Scopus)

2015

57. Radioprotectant and Cytotoxic Effects of Spirulina in Relapsed Verrucous Vulvar Cancer: A Case Report

KIZILTAN H. Ş., GÜNEŞ BAYIR A., Taspinar O., Yucesan G., Tastekin D., Sonmez F. C., et al.

ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE , cilt.21, ss.68-72, 2015 (SCI-Expanded, Scopus)

2015

58. Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation

Tatli A. M., Urakci Z., Kalender M. E., Arslan H., TAŞTEKİN D., Kaplan M. A.

Asian Pacific Journal of Cancer Prevention , cilt.16, sa.5, ss.2003-2007, 2015 (SCI-Expanded, Scopus)

2014

59. Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients

Tastekin D., Kargin S., KARABULUT M., Yaldiz N., Tambas M., Gurdal N., et al.

TUMOR BIOLOGY , cilt.35, sa.12, ss.11871-11877, 2014 (SCI-Expanded, Scopus)

2014

60. The efficacy of Pistacia Terebinthus soap in the treatment of cetuximab-induced skin toxicity

Tastekin D., Tambas M., KILIC K., Erturk K., ARSLAN D.

INVESTIGATIONAL NEW DRUGS , cilt.32, sa.6, ss.1295-1300, 2014 (SCI-Expanded, Scopus)

2014

61. Clinical significance of serum fibronectin and vitronectin levels in melanoma patients

Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.

MELANOMA RESEARCH , cilt.24, sa.5, ss.475-479, 2014 (SCI-Expanded, Scopus)

2014

62. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

TURAN N., Benekli M., DANE F., Unal O. U., Kara H. V., KOCA D., et al.

Thoracic cancer , cilt.5, sa.5, ss.398-404, 2014 (SCI-Expanded, Scopus)

2014

63. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer

Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.

TUMOR BIOLOGY , cilt.35, sa.9, ss.9303-9309, 2014 (SCI-Expanded, Scopus)

2014

64. The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer

Karabulut S., Tas F., Tastekin D., KARABULUT M., Yasasever C., Ciftci R., et al.

TUMOR BIOLOGY , cilt.35, sa.9, ss.8849-8860, 2014 (SCI-Expanded, Scopus)

2014

65. Clinical significance of serum tenascin-c levels in epithelial ovarian cancer

Didem T., Faruk T., Senem K., Derya D., Murat S., Murat G., et al.

TUMOR BIOLOGY , cilt.35, sa.7, ss.6777-6782, 2014 (SCI-Expanded, Scopus)

2014

66. Clinical significance of serum tenascin-C levels in breast cancer

Tastekin D., Tas F., Karabulut S., Duranyildiz D., Serilmez M., Guveli M., et al.

TUMOR BIOLOGY , cilt.35, sa.7, ss.6619-6625, 2014 (SCI-Expanded, Scopus)

2014

67. Assessment of tumor characteristics and factors affecting survival in patients with primary metastatic breast carcinoma: a Multicenter Study of the Anatolian Society of Medical Oncology

Uyeturk U., Oksuzoglu B., Akman T., Turker I., Sener N., Tastekin D., et al.

MEDICAL ONCOLOGY , cilt.31, sa.4, 2014 (SCI-Expanded, Scopus)

2014

68. Outcome of Daily Cisplatin with Thoracic Chemoradiotherapy in Advanced Non-small Cell Lung Cancer Patients with Comorbid Disorders: a Pilot Study

KIZILTAN H. Ş., Bayir A. G., Tastekin D., ÇOBAN G., Eris A. H., AYDIN T., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.20, ss.8591-8594, 2014 (SCI-Expanded, Scopus)

2014

69. Impact of Poster Presentations on Academic Knowledge Transfer from the Oncologist Perspective in Turkey

Arslan D., Koca T., Tastekin D., Basaran H., Bozcuk H.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.18, ss.7707-7711, 2014 (SCI-Expanded, Scopus)

2014

70. Clinicopathologic Features and Molecular Subtypes of Breast Cancer in Young Women (Age <= 35)

Goksu S. S., Tastekin D., Arslan D., Gunduz S., TATLI A. M., Unal D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.16, ss.6665-6668, 2014 (SCI-Expanded, Scopus)

2014

71. Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology

Mehmet K., Sener C., Uyeturk U., Seker M., Tastekin D., Tonyali O., et al.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , cilt.18, sa.4, ss.273-278, 2014 (ESCI, Scopus)

2013

72. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma

Tas F., Karabulut S., Bilgin E., Sen F., Yildiz I., Tastekin D., et al.

TUMOR BIOLOGY , cilt.34, sa.6, ss.3529-3536, 2013 (SCI-Expanded, Scopus)

2013

73. Rectal cancer in pregnancy: a case report and review of the literature.

Dogan N., Tastekin D., Kerimoglu O., Pekin A., Celik C.

Journal of gastrointestinal cancer , cilt.44, ss.354-6, 2013 (SCI-Expanded, Scopus)

2013

74. Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology

Berk V., Kaplan M. A., Tonyali O., Buyukberber S., Balakan O., ÖZKAN M., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.12, ss.7367-7369, 2013 (SCI-Expanded, Scopus)

2010

75. The biochemical effectiveness of N-acetylcysteine in experimental spinal cord injury in rats.

Hanci V., Kerimoğlu A., Koca K., Başkesen A., Kiliç K., Taştekin D.

Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES , cilt.16, ss.15-21, 2010 (SCI-Expanded, Scopus, TRDizin)

2009

76. [The opinions of Turkish physicians about the tasks of tuberculosis central dispensary].

Tanrikulu A., Palanci Y., Eren D., Yilmaz G., Karaca M., Abakay A., et al.

Tuberkuloz ve toraks , cilt.57, ss.32-7, 2009 (ESCI, Scopus, TRDizin)

2008

77. Correlation between the erythrocyte sedimentation rate and blood nitric oxide levels in rabbits?

Uzun M., Saral S., Atakisi O., Yapar K., Uzlu E., Citil M., et al.

Scandinavian Journal of Laboratory Animal Science , cilt.35, sa.1, ss.53-56, 2008 (SCI-Expanded, Scopus)

2008

78. Investigation of free radical scavenging enzyme activities and lipid peroxidation in liver tissue of zinc deficient rats

Kaya H., Taysi S., Kaya A., Boyuk A., DURSUN H., Islamoglu Y., et al.

Asian Journal of Chemistry , cilt.20, sa.2, ss.1068-1074, 2008 (SCI-Expanded, Scopus)

2006

79. Hypoglycaemic effect of Artemisia herba-alba in experimental hyperglycaemic rats

Taştekin D., ATASEVER M., Adigüzel G., Keleş M., Taştekin A.

Bulletin of the Veterinary Institute in Pulawy , cilt.50, sa.2, ss.235-238, 2006 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler

2023

1. PANKREAS KANSERLİ HASTALARIN PERiFERİK KANINDA EPS8 VE KANK1 GEN EKSPRESYONLARININ İNCELENMESİ

ÖZGEL M. Ç., AKDENİZ ÖDEMİŞ D., TUNÇER Ş. B., TAŞTEKİN D., YAZICI H.

9. uluslararası beslenme obezite ve toplum sağlığı kongresi, 28 - 29 Ekim 2023, (Özet Bildiri)

2020

2. Trastuzumab-based treatment of HER2-positive metastatic gastric cancer

Dogan I., Karabulut S., Tastekin D., Paksoy N., Sakar B., Vatansever S.

ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 Temmuz 2020, cilt.31, (Özet Bildiri)

2020

3. The frequencies and prognostic significance of ABO blood and rhesus (D) groups in HER2-positive gastric cancer

Dogan I., Gurbuz M., Aydin E., Tastekin D., Karabulut S., Utkan G.

ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 Temmuz 2020, cilt.31, (Özet Bildiri)

2020

4. Does nutritional status affect treatment tolarability, response, and survival in metastatic colorectal cancer patients? Results of prospective multicenter study

Karabulut S., Dogan I., Afsar C. U., Karabulut M., Karaman S., Ferhatoglu F., et al.

Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, San-Francisco, Kostarika, 23 - 25 Ocak 2020, cilt.38, (Özet Bildiri)

2016

5. Mide Kanserinde Serum Interleukin-29, Interleukin-32 ve Tumor Necrosis Factor Alpha'nın Klinik Önemi

ERTÜRK K., TAŞTEKİN D., SERİLMEZ M., BİLGİN DOĞRU E., H. U., VATANSEVER S.

3. Ulusal İmmüno-Onkoloji ve Hedefe Yönelik Kanser Tedavileri Kongresi, Antalya, Türkiye, 11 - 15 Mayıs 2016, ss.1, (Tam Metin Bildiri)

2016

6. Rektum kanserinde neoadj. sib-vmat yanıtının difüzyon MR ve serum apoptoz marker düzeyleri ile değerlendirilmesi

GÜRDAL N., FAYDA E. M., BAKIR B., Alishev N., GEZER U., TAŞTEKİN D., et al.

12. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 20 - 24 Nisan 2016, ss.45, (Tam Metin Bildiri)

2016

7. Rektum Kanserinde Neoadj. Sıb-Vmat Yanıtının Difüzyon Mr Ve Serum Apoptoz Marker Düzeyleri İle Değerlendirilmesi

GÜRDAL N., FAYDA E. M., BAKIR B., Alishev N., GEZER U., TAŞTEKİN D., et al.

12.Ulusal Radyasyon Onkolojisi Kongresi 20-24 Nisan 2016 Antalya, Antalya, Türkiye, 20 Nisan 2016, (Özet Bildiri)

2015

8. Nüks meme kanserinde reoperatif sentinel lenf nodu biyopsisi: Aksilla korunabilir mi?

Karanlık H., Özgür İ., Kılıç B., Şanlı Y., Önder S., Taştekin D., et al.

13. Ulusal Meme Hastalıkları Kongresi, 2015, Antalya, Türkiye, 21 - 25 Ekim 2015, ss.1, (Özet Bildiri)

2015

9. Neoadjuvant Volumetric Modulated Arc Therapy Simultaneous Integrated Boost SIB VMAT With Concurrent Chemotherapy in Rectal Adenocarcinomas and the Correlation of Pathological Response With Diffusion Weighted MRI and Apoptotic Markers 2325

GÜRDAL N., FAYDA M., BAKIR B., ALİSHEV N., GEZER U., TAŞTEKİN D., et al.

2015 ASTRO - Radiation Oncology Annual Meeting, San-Antonio, Kuzey Mariana Adaları, 18 - 21 Ekim 2015, ss.128

2015

10. The prognostic value of lymph node ratio in patients with curatively resected pancreatic adenocarcinoma.

Turan N., Araz M., Algin E., Unal O. U., Benekli M., Tastekin D., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)

2015

11. The role of adhesion molecules in hepatocellulary carcinoma

Tastekin D., DIKILITAS M., HARPUTLUOGLU H., Erturk K., CELEBI K., Sen F., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)

2015

12. Serum Hepatosit Büyüme Faktörünün Akciğer Kanserli Hastalarda Tanısal Değeri

ŞEN F., BOZBEY H., ÇİFTÇİ R., KILIÇ L., YILDIZ İ., TAŞTEKİN D., et al.

21. Ulusal Kanser Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.1, (Tam Metin Bildiri)

2015

13. Hepatosellüler karsinomda galektin-3 ve fibronektin molekülleri yeni bir tümör belirteci olabilir mi?

SERİLMEZ M., AKYÜZ M., TAŞTEKİN D., OĞUZ SOYDİNÇ H., DURANYILDIZ D.

21. Ulusal Kanser Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.1, (Tam Metin Bildiri)

2014

14. Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.

CIFTCI R., Tas F., AKSIT E., Vatansever S., KARABULUT S., Sen F., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)

2014

15. Clinical significance of serum epithelial cell adhesion molecule (EPCAM) cud vascular cell adhesion molecule-1 (VCAM-1) levels in lung cancer.

KARABULUT S., Tastekin D., CIFTCI R., Tambas M., DAGOGLU N., Guveil M. E., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)

2014

16. Clinical significance of serum caveolin-1 levels in melanoma.

Tastekin D., KARABULUT S., DURANYILDIZ D., Tas F.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)

2014

17. Metastatik rektum kanseri olgularında kısa dönem radyoterapinin katkısı

İBİŞ K., ÖZKURT S., DAĞOĞLU SAKİN R. N., KAYTAN SAĞLAM E., TAŞTEKİN D., KESKİN M., et al.

11. Ulusal Radyasyon Onkolojisi Kongresi, Türkiye, 23 Nisan 2014, (Özet Bildiri)

2014

18. Nazal Kavite Kaynaklı Tipik Karsinoid Tümör: Olgu sunumu

Gürdal N., Taştekin D., Güveli M. E., Özkaya K., Meral R., Altun M.

11. Ulusal Radyasyon Onkolojisi Kongresi, 23-27 Nisan 2014 ANTALYA, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.170, (Özet Bildiri)

2014

19. Platin dirençli nüks eden baş boyun tümörlerinde setuximabın rolü, olgu değerlendirmesi

Karabulut S., Ekenel M., Tambaş M., Taştekin D., Altun M., Meral R., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, ss.363, (Tam Metin Bildiri)

2013

20. The effects of variability of mean erythrocyte corpuscular volume (MCV) in patients with advanced stage gastrointestinal stromal tumor (GIST) using imatinib on progression free survival

Cetin B., TAŞTEKİN D., Aktas B., Guler T., Kaplan M. A., Berk V., et al.

European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri)

2013

21. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma

Ciftci R., Karabulut S., Tastekin D., Sen F., Kilic L., Yildiz I., et al.

European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Hollanda, 27 Eylül - 01 Ekim 2013, cilt.49, (Özet Bildiri)

2013

22. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

Turan N., Dane F., Unal O. U., Benekli M., Kara H. V., Koca D., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

2013

23. Comparison of mucosal and cutaneous melanoma in the head and neck region: Different clinical features and similar outcomes.

Ciftci R., Keskin S., Karabulut S., Yildiz I., Kilic L., Sen F., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

2013

24. Coagulation assays in breast cancer: Correlation of plasma D-dimer with tumor load and invasiveness in breast cancer patients.

Karabulut S., Kilic L., Ciftci R., Yildiz I., Sen F., Keskin S., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

Kitaplar

2024

1. High-Dose Vitamin C Is an Unorthodox Approach to Cancer Treatment

Şen S., Ugar M., Bozbey H. U., Taştekin D.

Original Research and Reviews in the Field of Medical Oncology, selim güngör, Editör, Platanus Publishing, Ankara, ss.5-44, 2024

2024